MedTrace Logo

Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users

NCT05886504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 567

Last updated 2026-04-15

No results posted yet for this study

Summary

The main objective of this study is to show that People Who Inject Drugs (PWID) suffering initially from a major depressive disorder, a psychotic disorder and/or had a suicide risk and who received a community-based psychiatric intervention improve sustainably their mental health and are comparable after intervention to a population of PWID free of these disorders in terms of:

* HIV/HCV exposure
* Severity of substance use
* Quality of life This is prospective one-year cohort study comparing 200 PWID diagnosed with a psychiatric disorder with 400 controls (200 PWID living with HIV and 200 PWID non-infected with HIV, both free of a diagnosis of depression, psychosis, suicidal risk at cohort initiation).

Psychiatric intervention includes free psychiatric consultations and medications (issued on CBO sites), support from CBO members for appointments, information, treatment adherence, contact with families and tracing of those lost to follow-up. Target population and controls will also be proposed linkage to care (HIV, methadone) and harm reduction services.

Conditions

  • Psychiatric Disorder
  • Drug Use

Interventions

OTHER

Community-based psychiatric intervention

intervention will take place in CBO offices instead of mental health department, medication will be given freely and psychiatric consultations will be free. Trained CBO members will provide individual and collective support including recall of appointments and tracing of those lost to follow-up, information on mental health, main psychiatric disorders, psychiatric medication, their potential side effects and expected benefits, contact with families and continuous support

Sponsors & Collaborators

  • Centre Pierre Nicole Croix-Rouge française

    collaborator UNKNOWN

  • Haiphong University of Medicine and Pharmacy

    collaborator OTHER

  • Université Montpellier

    collaborator OTHER

  • Center for supporting Community Developement Initiatives Hai Phong

    collaborator UNKNOWN

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-28
Primary Completion
2023-05-28
Completion
2024-07-28

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05886504 on ClinicalTrials.gov